 |
|
|
| |
|
Borderline Personality Disorder:
Origins,
Treatments, and Family Perspectives
|
|
Saturday,
May 7, 2005 • Mary
S. Harkness Auditorium,
New
Haven, CT
|
|
Sponsored by:
|
The
National Education Alliance for Borderline Personality Disorder (NEA-BPD)
in
partnership
with the National Alliance for Research on Schizophrenia and Depression
(NARSAD)
|
|
In cooperation with:
|
Yale-New
Haven Psychiatric Hospital
Department
of Psychiatry, Yale
University School of Medicine
The
National Alliance for the Mentally Ill-Connecticut
|
|
Conference Objectives |
At
the conclusion of the conference, attendees will be better able to identify,
specify, and describe:
1.
The symptomatology of BPD
2.
The current understanding of emotion dysregulation
3.
The complexities of the diagnostic issues surrounding BPD
4.
Issues of concern to consumers and family members
5.
Research design elements and outcomes of a family program
6.
The problems and options of medication programs for people with BPD
7.
Three psychosocial treatment modalities
|
|
Course Description |
The
Conference is for physicians, psychiatrists, psychologists, social workers,
family therapists, counselors, nurses, emergency room personnel, law enforcement
personnel and agencies, family members, consumers, and educators.
Continuing
Education credits for social workers and Certificates of Attendance are
also available upon request. |
|
Statement of Need |
Borderline
Personality Disorder (BPD) is a severe and generally chronic
disorder and people who suffer from it are underserved. Friends and families
are often bewildered and do not know how to help. Treatment programs for
those with BPD need to be more readily available. Families need access
to programs such as those already developed for several other mental illnesses.
BPD presents patients, their families and researchers with multiple challenges.
These complex challenges will be addressed in order to inform mental health
professionals, families, and consumers of the most current diagnostic and
treatment options available, and other issues of current interest to those
affected by the disorder. |
| |
|
Conference Program |
8:30
am
. |
Welcome |
Perry
D. Hoffman, PhD
The
Mount Sinai School of Medicine
President,
NEA-BPD
Seth
R. Axelrod, PhD
Assistant
Professor of Psychiatry
Intensive
Outpatient Program DBT/DBT-S Team Leader
Yale-New
Haven Psychiatric Hospital
Yale
University School of Medicine
|
|
Opening
Remarks |
Benjamin
S. Bunney, MD
Charles
B.G. Murphy Professor and Chairman of Psychiatry
Professor
of Pharmacology
Yale
University School of Medicine
|
|
Moderator
for the day: Seth R. Axelrod, PhD
|
| 8:45
am. |
Borderline
Personality Disorder: What Is It? |
Robert
Stern, MD, PhD
Associate
Clinical Professor of Psychiatry
Yale
University School of Medicine
|
| 9:30
am |
Biopsychology
of Emotion Dysregulation |
Rajita
Sinha, PhD
Associate
Professor of Psychiatry
Director,
Research Program on Stress, Addiction and Psychopathology
Director,
Addiction Services
Connecticut
Mental Health Center
Yale
University School of Medicine
|
| 10:30
am |
Disclosing
the BPD Diagnosis: Practice and Recommendations |
Richard
G. Hersh, MD
Assistant
Clinical Professor of Psychiatry
Columbia
University College of Physicians and Surgeons
Assistant
Director of the Intensive Outpatient Program
Columbia
Presbyterian Medical Center
|
| 11:15
am |
Family
and Consumer Perspectives Panel, and Family Research |
Executive
Vice-President, NEA-BPD
Administrative
Director
Center
for the Study of Issues in Public Health
Nathan
Kline Institute for Psychiatric Research
Perry
D. Hoffman, PhD
Ellie
Buteau, PhD
|
| 1:30
pm |
Psychopharmacology
of BPD: Benefits and Limitations |
Kenneth
R. Silk, MD
Professor
and Associate Chair
Clinical
and Administrative Affairs
Department
of Psychiatry
University
of Michigan Health System
|
| 2:15
pm |
Transference-Focused
Psychotherapy |
Frank
E.Yeomans, MD, PhD
Director
of Training
Personality
Disorders Institute
Clinical
Associate Professor of Psychiatry
Weill
School of Medicine at Cornell University
|
| 3:00
pm |
Dialectical
Behavior Therapy |
George
H. Davis, PhD
Clinical
Director
Center
for Dialectical and Cognitive Behavioral Therapies
Assistant
Clinical Professor of Psychiatry
Yale
University School of Medicine
|
| 3:30
pm |
Schema-Focused
Therapy |
Samuel
A. Ball, PhD
Associate
Professor of Psychiatry
Director
of Training, NIDA Clinical Trials Network (New England Node)
Director
of Residential Services, APT Foundation
Yale
University School of Medicine
Veterans
Administration Connecticut Healthcare
|
| 4:00
pm |
Treatment
Panel: Question and Answer Time |
|
. |
| |
|
|
|
|
|
Site by AMS Web Services
|
|